medline.ch Gastroenterologie Magen-Darm Entzündliche Darmerkrankungen

	Assessment of transmural treatment response in known Crohn's disease: a prospective blinded study of the intermodality agreement between intestinal ultrasound and magnetic resonance enterography. BMJ Open Gastroenterol Brodersen JB, Rafaelsen SR, Nejatbakhsh E, Jensen MD. PMID: 41663130 [PubMed - indexed for MEDLINE]
	Mechanistic study of Dendrobium huoshanense polysaccharides improving ulcerative colitis by promoting Lachnoclostridium edouardi metabolism of short-chain fatty acids. J Ethnopharmacol Fang J, Wu M, Yu J, Zhao J, Liu Y, Cui Y, Chen Y, Han S, Chen W, Peng D, Yao L. PMID: 41663002 [PubMed - as supplied by publisher]
	Optimal use and cycling strategies of Janus kinase inhibitors in ulcerative colitis: current evidence and clinical implications from the KASID Guidelines Task Force Team. Intest Res Hong SM, Kim DH, Bae JH, Shin SY, Song EM, Kim JE, Yang YJ, Yoon J, Kang SB, Kim ES, Kim SE, Kim SJ, Lee J, Na SY, Park SJ, Park SH, Choi M, Kim MH, Moon W, Jung SA. PMID: 41662833 [PubMed]
	Therapeutic Efficacy of Risankizumab for Small Intestinal Lesions in Crohn's Disease: A Retrospective Study Using Double-Balloon Endoscopy. Digestion Yamamura T, Sawada T, Ishikawa E, Maeda K, Murate K, Furukawa K, Hirose T, Iida T, Mizutani Y, Yamao K, Ishizu Y, Ishikawa T, Honda T, Nakamura M, Kawashima H. PMID: 41662301 [PubMed - as supplied by publisher]
	Time-Restricted Feeding Reduces Body Mass Index, Visceral Adiposity, Systemic Inflammation, and Clinical Disease Activity in Adults With Crohn's Disease: A Randomized Controlled Study. Gastroenterology Haskey N, Ye J, Lewis A, Yousuf M, Reimer RA, Raman M. PMID: 41661119 [PubMed - as supplied by publisher]
	Effect of Disease Extent on Leucine-Rich Î±2-Glycoprotein as a Marker for Endoscopic Mucosal Healing in Patients With Ulcerative Colitis. JGH Open Kitahata S, Saito M, Kimura Y, Nakamura A, Usui T, Kato K, Onishi K, Kanemitsu-Okada K, Kawamura T, Ohama H, Kuroda T, Matsuoka J, Tada F, Miyata H, Hiraoka A, Tsubouchi E, Ninomiya T, Hiasa Y. PMID: 41658961 [PubMed]
	Natural products targeting the MAPK signaling pathway: potential options for ulcerative colitis treatment. Front Pharmacol Li C, Li Z, Zheng Y. PMID: 41657779 [PubMed]
	Rapid symptomatic improvement with etrasimod in ulcerative colitis: a post-hoc analysis of the ELEVATE UC program. Inflamm Bowel Dis Dubinsky MC, Chaparro M, Irving PM, Hur P, Sidhu S, Woolcott JC, Wang W, Goetsch M, Torres J, Panaccione R. PMID: 41655066 [PubMed - as supplied by publisher]
	Histopathological Findings of Appendix Specimens in Quiescent Ulcerative Colitis: Correlations With Clinical Outcomes in the ACCURE Trial. United European Gastroenterol J Visser E, Danielsson D, Heuthorst L, D'Haens GR, Bemelman WA, Buskens CJ, Mookhoek A. PMID: 41653087 [PubMed - indexed for MEDLINE]
	Diagnostic accuracy of endoscopic findings for cytomegalovirus reactivation in hospitalized patients with ulcerative colitis. PLoS One Aoi M, Nakamura N, Honzawa Y, Fukata N, Naganuma M. PMID: 41650111 [PubMed - indexed for MEDLINE]
	Ferroptosis as a mediator of gut microbiota-driven inflammatory bowel disease: Evidence from genetic analyses. Medicine (Baltimore) Xu X, Ye H, Ren Q, Shao X, Wang J, Shi Y, Du Y. PMID: 41650031 [PubMed - indexed for MEDLINE]
	Filiform Polyposis of the Terminal Ileum as the Initial Manifestation of Crohn's Disease: A Case Report. Am J Case Rep Feng M, Xiao Q, Mo D, Xu Y, Chen Y, Lu C. PMID: 41649985 [PubMed - indexed for MEDLINE]
	Comparative Safety of Advanced Therapies for Crohn Disease. JAMA Netw Open Park SK, Ahuja D, Yeh KH, Patel SB, Goodwin SW, Ma C, Singh N, Ananthakrishnan AN, Jairath V, Xu R, Singh S. PMID: 41649814 [PubMed - indexed for MEDLINE]
	Nutrient requirements for adults with ulcerative colitis over the disease course: a systematic scoping review. Crit Rev Food Sci Nutr Plush S, Bryant RV, Davis RH, Kumar S, Day AS. PMID: 41649484 [PubMed - as supplied by publisher]
	The interplay mechanisms between gut microbiota and ferroptosis in inflammatory bowel disease. Front Immunol Shi Z, Zhang S, Zhai H, Wu Q, Li Y, Xu H, Zhang S. PMID: 41646847 [PubMed - indexed for MEDLINE]
	A Multi-Mineral Intervention Improves Intestinal Permeability in Patients with Ulcerative Colitis: Results from a 90-Day Pilot Trial. medRxiv Aslam MN, Turgeon DK, McClintock S, Allen R, Sen A, Varani J. PMID: 41646788 [PubMed]
	Redrawing the gut map: evolving probiotic approaches to microbiota modulation in inflammatory bowel disease. Antonie Van Leeuwenhoek Vaghela P, Dave B, Dabhade A, Deshmukh R, Prajapati B, Alsaidan OA, Patel S, Mehta A, Singh A, Dudhat K. PMID: 41644858 [PubMed - indexed for MEDLINE]
	Optimizing vedolizumab therapy in ulcerative colitis: A critical synthesis of trial evidence and the emerging role of artificial intelligence. PLOS Digit Health Abdulfattah A. PMID: 41642870 [PubMed]
	MicroRNAs as novel therapeutic targets against inflammatory bowel disease through modulation of ferroptosis. Clin Exp Med Bu S, Chen M, Li J, Zhang T, Yu Y. PMID: 41642459 [PubMed - indexed for MEDLINE]
	Latent tuberculosis screening for inflammatory bowel disease in tuberculosis endemic region remains porous and suboptimal: A multicentre study. World J Gastroenterol Jha DK, Prasad S, Valsan A, Mishra S, Nair P, Koshy AK, Singh S, Prasad AS, Shukla R, Ahamed R, Augustine P, Natarajan K, Peddi K, Kulkarni A, Bhatia S, Pachisia AV, Singh PK, Jena A, Gupta S, Jain S, Padmaprakash K, Kakadiya R, Kumar A, Shukla S, Dutta U, Hande V, Thareja S, Sharma V. PMID: 41640875 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 56686

Seite 1 von 2835



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung